Although some tumor marker tests are in clinical use, these markers have not been fully validated and most of them are less specific compared with cytology. Therefore, newer methods of detection ...
In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...
The next step for the researchers is to verify the effectiveness of the method on a more widespread scale so they can seek government approval to put the innovative test technique into clinical use.
Since the FDA approval of CA-125 as a tumor marker test, when a pelvic mass could be an ovarian carcinoma, clinicians are turning to this test as a tool in the diagnostic investigation.